OTC Markets OTCPK - Delayed Quote USD
Innovent Biologics, Inc. (IVBXF)
5.97
0.00
(0.00%)
At close: April 22 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
147,810
147,810
-1,918,804
-2,024,843
-307,688
Investing Cash Flow
-998,662
-998,662
-1,435,185
-2,698,148
-5,184,588
Financing Cash Flow
2,587,257
2,587,257
2,892,082
5,003,361
4,912,121
End Cash Position
2,745,693
2,745,693
1,016,165
1,359,408
1,276,178
Capital Expenditure
-1,383,460
-1,383,460
-1,381,730
-1,847,516
-771,778
Issuance of Capital Stock
2,255,116
2,255,116
2,131,059
3,950,520
4,662,363
Issuance of Debt
1,335,549
1,335,549
1,080,172
1,463,083
372,178
Repayment of Debt
-917,050
-917,050
-365,000
-255,000
-17,000
Free Cash Flow
-1,235,650
-1,235,650
-3,300,534
-3,872,359
-1,079,466
12/31/2020 - 9/4/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GLPGF Galapagos NV
22.39
0.00%
GNMSF Genmab A/S
198.11
0.00%
GOVXW GeoVax Labs, Inc.
0.0300
-0.33%
TLPPF Telix Pharmaceuticals Limited
18.00
+6.19%
CSLLY CSL Limited
76.40
-0.05%
IMMX Immix Biopharma, Inc.
1.7100
0.00%
APGE Apogee Therapeutics, Inc.
36.53
+2.90%
ACIU AC Immune SA
1.5800
+5.33%
MIRM Mirum Pharmaceuticals, Inc.
39.62
+0.48%
ACLX Arcellx, Inc.
63.63
+0.81%